Sequential intrathoracic injection and intravenous infusion of BCMA CAR-T cells in a patient with relapsed/refractory primary plasma cell leukemia
- 10.09.2025
- Case Report
- Verfasst von
- Wei Han
- Shuyang Wang
- Mingming Zhang
- Shan Fu
- Wenjun Wu
- Houli Zhao
- Ka Wai Wong
- Sze Fai Yip
- Jiazhen Cui
- Alex H. Chang
- Guoqing Wei
- He Huang
- Yongxian Hu
- Erschienen in
- International Journal of Hematology | Ausgabe 6/2025
Abstract
Patients with primary plasma cell leukemia (pPCL), particularly those with extramedullary disease (EMD), face a poor prognosis even with chimeric antigen receptor (CAR)-T cell therapy. This case report describes a patient with relapsed/refractory pPCL and life-threatening malignant pleural effusion (PE) treated with intrapleural CAR-T cells targeting B-cell maturation antigens. CAR-T cell expansion within the PE was observed, along with a rapid reduction in leukemia cell count and PE volume. Subsequent lymphodepletion chemotherapy and intravenous CAR-T cell therapy induced complete remission with 9 months of progression-free survival. This case highlights the potential advantages of integrating local and systemic CAR-T cell therapy in managing complex EMD cases.
Anzeige
- Titel
- Sequential intrathoracic injection and intravenous infusion of BCMA CAR-T cells in a patient with relapsed/refractory primary plasma cell leukemia
- Verfasst von
-
Wei Han
Shuyang Wang
Mingming Zhang
Shan Fu
Wenjun Wu
Houli Zhao
Ka Wai Wong
Sze Fai Yip
Jiazhen Cui
Alex H. Chang
Guoqing Wei
He Huang
Yongxian Hu
- Publikationsdatum
- 10.09.2025
- Verlag
- Springer Nature Singapore
- Erschienen in
-
International Journal of Hematology / Ausgabe 6/2025
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774 - DOI
- https://doi.org/10.1007/s12185-025-04064-3
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.